168 related articles for article (PubMed ID: 385138)
1. Etoposide (VP-16-213).
Issell BF; Crooke ST
Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
[No Abstract] [Full Text] [Related]
2. Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent.
Sinkule JA
Pharmacotherapy; 1984; 4(2):61-73. PubMed ID: 6326063
[TBL] [Abstract][Full Text] [Related]
3. [New antineoplastic drugs of the podophyllotoxin derivative group].
Robak T; Płuzańska A
Pol Tyg Lek; 1983 Jan; 38(1):27-30. PubMed ID: 6346283
[No Abstract] [Full Text] [Related]
4. Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report.
Chard RL; Krivit W; Bleyer WA; Hammond D
Cancer Treat Rep; 1979; 63(11-12):1755-9. PubMed ID: 294306
[TBL] [Abstract][Full Text] [Related]
5. Etoposide--an effective single drug for treating bronchogenic carcinoma.
Anderson G; Peel ET; Cheong CM; Broderick NJ
Clin Oncol; 1982; 8(3):215-8. PubMed ID: 7140048
[No Abstract] [Full Text] [Related]
6. VP-16-213 (etoposide): the mandrake root from Issyk-Kul.
Vogelzang NJ; Raghavan D; Kennedy BJ
Am J Med; 1982 Jan; 72(1):136-44. PubMed ID: 6277188
[TBL] [Abstract][Full Text] [Related]
7. [Etoposide: VP-16].
Dicato M
Bull Soc Sci Med Grand Duche Luxemb; 1982; 119(2):15-8. PubMed ID: 7160031
[No Abstract] [Full Text] [Related]
8. VM 26 and VP 16-213: a comparative analysis.
Rozencweig M; Von Hoff DD; Henney JE; Muggia FM
Cancer; 1977 Jul; 40(1):334-42. PubMed ID: 328129
[TBL] [Abstract][Full Text] [Related]
9. Etoposide (VP-16-213). Current status of an active anticancer drug.
O'Dwyer PJ; Leyland-Jones B; Alonso MT; Marsoni S; Wittes RE
N Engl J Med; 1985 Mar; 312(11):692-700. PubMed ID: 2983208
[No Abstract] [Full Text] [Related]
10. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
[No Abstract] [Full Text] [Related]
11. Podophyllotoxin derivative VP 16-213.
Arnold AM
Cancer Chemother Pharmacol; 1979; 3(2):71-80. PubMed ID: 389478
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Radice PA; Bunn PA; Ihde DC
Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
[No Abstract] [Full Text] [Related]
13. Review of etoposide.
Phillips NC; Lauper RD
Clin Pharm; 1983; 2(2):112-9. PubMed ID: 6309469
[No Abstract] [Full Text] [Related]
14. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
Slayton RE; Creasman WT; Petty W; Bundy B; Blessing JA
Cancer Treat Rep; 1979; 63(11-12):2089-92. PubMed ID: 526942
[No Abstract] [Full Text] [Related]
15. Simple method for the administration of high-dose etoposide during autologous bone marrow transplantation.
Lazarus HM; Creger RJ; Diaz D
Cancer Treat Rep; 1986 Jun; 70(6):819-20. PubMed ID: 3524832
[No Abstract] [Full Text] [Related]
16. Comparison of a water-soluble and a water-insoluble podophyllotoxin derivative in murine neoplasms.
Kreis W; Soricelli A
J Cancer Res Clin Oncol; 1979; 95(3):233-7. PubMed ID: 528564
[TBL] [Abstract][Full Text] [Related]
17. Does etoposide have curative potential?
Ignoffo RJ
Clin Pharm; 1983; 2(2):167. PubMed ID: 6309470
[No Abstract] [Full Text] [Related]
18. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
Sanz Ortíz J; Saiz García F
Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
[No Abstract] [Full Text] [Related]
19. Effect of hemostasis modifiers of the activity of VP 16 213 on Lewis lung carcinoma.
Cattan A; Pourny C; Carpentier Y; Cattan E; Barouh M
Biomedicine; 1977 Jul; 27(5):203-8. PubMed ID: 922120
[No Abstract] [Full Text] [Related]
20. Teniposide: a review of 12 years of experience.
O'Dwyer PJ; Alonso MT; Leyland-Jones B; Marsoni S
Cancer Treat Rep; 1984 Dec; 68(12):1455-66. PubMed ID: 6391663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
